Barclays’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.57M Buy
1,301,911
+858,572
+194% +$2.72M ﹤0.01% 2019
2025
Q4
$1.64M Buy
443,339
+107,730
+32% +$348K ﹤0.01% 3073
2025
Q3
$889K Sell
335,609
-26,100
-7% -$50.5K ﹤0.01% 3439
2025
Q2
$356K Buy
361,709
+125,576
+53% +$126K ﹤0.01% 3948
2025
Q1
$340K Sell
236,133
-123,102
-34% -$227K ﹤0.01% 3761
2024
Q4
$790K Buy
359,235
+49,564
+16% +$116K ﹤0.01% 3529
2024
Q3
$511K Buy
309,671
+154,509
+100% +$312K ﹤0.01% 3763
2024
Q2
$344K Buy
155,162
+50,678
+49% +$119K ﹤0.01% 3267
2024
Q1
$280K Sell
104,484
-16,600
-14% -$40.3K ﹤0.01% 3928
2023
Q4
$362K Buy
121,084
+32,100
+36% +$41.6K ﹤0.01% 4082
2023
Q3
$87.2K Sell
88,984
-14,664
-14% -$21.2K ﹤0.01% 3641
2023
Q2
$144K Sell
103,648
-56,779
-35% -$79.3K ﹤0.01% 3405
2023
Q1
$255K Sell
160,427
-2,594
-2% -$13.4K ﹤0.01% 3662
2022
Q4
$1.02M Buy
163,021
+121,325
+291% +$868K ﹤0.01% 2784
2022
Q3
$280K Buy
41,696
+13,617
+48% +$93.5K ﹤0.01% 3020
2022
Q2
$178K Sell
28,079
-6,983
-20% -$39.6K ﹤0.01% 3499
2022
Q1
$163K Sell
35,062
-60,636
-63% -$260K ﹤0.01% 3544
2021
Q4
$480K Buy
95,698
+47,092
+97% +$377K ﹤0.01% 3225
2021
Q3
$585K Buy
48,606
+14,300
+42% +$208K ﹤0.01% 3105
2021
Q2
$726K Sell
34,306
-3,714
-10% -$89.4K ﹤0.01% 2859
2021
Q1
$1.07M Sell
38,020
-17,605
-32% -$519K ﹤0.01% 2735
2020
Q4
$1.45M Buy
55,625
+43,764
+369% +$1.31M ﹤0.01% 2498
2020
Q3
$441K Sell
11,861
-173,332
-94% -$6.87M ﹤0.01% 3320
2020
Q2
$9.5M Buy
185,193
+5,985
+3% +$250K 0.02% 994
2020
Q1
$5.65M Buy
179,208
+71,195
+66% +$3.76M 0.01% 1372
2019
Q4
$6.44M Buy
108,013
+83,406
+339% +$3.75M 0.01% 1772
2019
Q3
$903K Sell
24,607
-7,495
-23% -$297K ﹤0.01% 3761
2019
Q2
$1.49M Buy
32,102
+24,108
+302% +$1.13M ﹤0.01% 3253
2019
Q1
$321K Sell
7,994
-3,314
-29% -$149K ﹤0.01% 4475
2018
Q4
$520K Buy
11,308
+2,730
+32% +$132K ﹤0.01% 3782
2018
Q3
$381K Buy
8,578
+2,491
+41% +$114K ﹤0.01% 4491
2018
Q2
$239K Sell
6,087
-19,693
-76% -$995K ﹤0.01% 4567
2018
Q1
$1.86M Sell
25,780
-39,917
-61% -$2.93M ﹤0.01% 2532
2017
Q4
$4.33M Buy
65,697
+64,158
+4,169% +$3.45M 0.01% 1781
2017
Q3
$77K Sell
1,539
-76,167
-98% -$3.67M ﹤0.01% 5104
2017
Q2
$3.6M Buy
77,706
+58,431
+303% +$2.15M 0.01% 1730
2017
Q1
$681K Buy
19,275
+3,123
+19% +$71.5K ﹤0.01% 3102
2016
Q4
$201K Buy
16,152
+15,878
+5,795% +$189K ﹤0.01% 4210
2016
Q3
$4K Sell
274
-114
-29% -$1.29K ﹤0.01% 6068
2016
Q2
$4K Buy
388
+200
+106% +$3.31K ﹤0.01% 5785
2016
Q1
$3K Sell
188
-1,487
-89% -$23.9K ﹤0.01% 5787
2015
Q4
$37K Sell
1,675
-37,708
-96% -$951K ﹤0.01% 4954
2015
Q3
$904K Buy
39,383
+34,480
+703% +$2.16M ﹤0.01% 2822
2015
Q2
$397K Buy
4,903
+3,754
+327% +$367K ﹤0.01% 3662
2015
Q1
$105K Buy
1,149
+247
+27% +$15.9K ﹤0.01% 4815
2014
Q4
$36K Sell
902
-749
-45% -$22.9K ﹤0.01% 5954
2014
Q3
$39K Sell
1,651
-1,865
-53% -$29.6K ﹤0.01% 6064
2014
Q2
$53K Buy
3,516
+779
+28% +$11.3K ﹤0.01% 5891
2014
Q1
$41K Buy
2,737
+2,635
+2,583% +$40.9K ﹤0.01% 6149
2013
Q4
$1K Sell
102
-248
-71% -$3.61K ﹤0.01% 7436
2013
Q3
$7K Buy
+350
New +$5.88K ﹤0.01% 6893

Other funds holding ESPR